Manuel Cobo

机构：Hospital Regional Universitario de Málaga, Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga · ORCID：0000-0003-3402-1144

发表论文 548 篇 · 总被引 29205 次 · h-index 58

代表论文

• Data from First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non–Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study (2026)
• Supplementary Data 1 from First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non–Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study (2026)
• Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer (2026 · Clinical Cancer Research)
• Figure S7 from Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer (2026)
• Table S11 from Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer (2026)
• Table S6 from Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer (2026)